Serum exosomal and serum glypican-1 are associated with early recurrence of pancreatic ductal adenocarcinoma

Serum exosomal and serum glypican-1 are associated with early recurrence of pancreatic ductal adenocarcinoma

BackgroundThe diagnostic performance and prognostic value of serum exosomal glypican 1 (GPC-1) in pancreatic ductal adenocarcinoma (PDAC) remain controversial. In this study, we detected serum exosomal GPC-1 using enzyme-linked immunosorbent assay (ELISA) and determined whether it serves as a predic...

Full description

Bibliographic Details
Main Authors: Juan Zhao, Madi Guo, Yushuai Song, Shan Liu, Ran Liao, Yu Zhang, Yumin Zhang, Qi Yang, Yuanlong Gu, Xiaoyi Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
pancreatic ductal adenocarcinoma
exosome
glypican 1
diagnosis
early recurrence
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.992929/full

Similar Items

Similar Items